Contact this trialFirst, we need to learn more about you.
Janus Kinase (JAK) Inhibitor
Upadacitinib for Crohn's Disease
Recruiting1 awardPhase 2
Marietta, Georgia
This trial will study the long-term effects of a medication called Upadacitinib. Researchers will evaluate how well the drug works, how safe it is, and how well people tolerate it.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service